Researchers have confirmed that balloon angioplasty is safe and could be an effective way to treat the venous abnormalities of people with multiple sclerosis (MS) and relieve their symptoms. The findings contradict a common misconception about CCSVI treatment, and were presented March 25 2012 at the Society of Interventional Radiology (SIR) scientific meeting in San Francisco.
“These early results show that performing angioplasty on azygos and jugular vein lesions may have a positive impact on the symptoms of those individuals with MS and also could be an effective palliative treatment geared toward improving their quality of life,” said Hector Ferral, MD, an interventional radiologist at NorthShore University HealthSystem in Evanston, Illinois.
“Our experience showed that 95 percent of the individuals we evaluated had venous obstructions, supporting the concept that venous lesions are common in individuals with multiple sclerosis,” Ferral said.
“Based on follow-up that included ultrasound one week post procedure and clinic visits every three months, our results showed that people who have this treatment are not exposed to fatal risks. It is our belief that portraying venous angioplasty of the azygos and jugular veins as a high-risk procedure is a widespread misconception that needs to be addressed and corrected,” he added.
This retrospective study looked at the results of 105 balloon angioplasty procedures carried out in 94 individuals with MS (aged 26-67 years old; 35 men and 59 women). The study’s subgroups were made up of 50 percent relapsing remitting, 39 percent secondary progressive, 6.4 percent primary progressive and 4.2 percent unknown types of multiple sclerosis.
Please read part two of this article for further results.